A vaccine targeted specifically to prevent cerebral malaria – is there hope?
- 25 June 2018
- journal article
- editorial
- Published by Taylor & Francis in Expert Review of Vaccines
- Vol. 17 (7) , 565-567
Abstract
Malaria remains a major infectious disease burden on health in large parts of the world. The disease is estimated to claim close to half a million lives a year, in addition to untold suffering, mai...Keywords
Funding Information
- not funded
This publication has 19 references indexed in Scilit:
- Severe adult malaria is associated with specific PfEMP1 adhesion types and high parasite biomassProceedings of the National Academy of Sciences, 2016
- Preparing for future efficacy trials of severe malaria vaccinesVaccine, 2016
- Brain Swelling and Death in Children with Cerebral MalariaNew England Journal of Medicine, 2015
- PfEMP1 – A Parasite Protein Family of Key Importance in Plasmodium falciparum Malaria Immunity and Pathogenesis2015
- Structural Conservation Despite Huge Sequence Diversity Allows EPCR Binding by the PfEMP1 Family Implicated in Severe Childhood MalariaCell Host & Microbe, 2015
- The Role of Animal Models for Research on Severe MalariaPLOS Pathogens, 2012
- The case for PfEMP1-based vaccines to protect pregnant women againstPlasmodium falciparummalariaExpert Review of Vaccines, 2011
- Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up studyThe Lancet, 2011
- Malaria in pregnancy: pathogenesis and immunityThe Lancet Infectious Diseases, 2007
- Protective Immunity produced by the Injection of X-irradiated Sporozoites of Plasmodium bergheiNature, 1967